A recent study shows that bacteria living inside colorectal tumors form distinct ecosystems that are closely linked to how ...
Latest DWP statistics reveal which health conditions are most likely to receive long-term Attendance Allowance payments ...
Crofelemer has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency for SBS and MVID. In October 2025, as announced, the company ...
When inflammation in the body goes unchecked, it can cause fibrosis, or tissue scarring that may lead to organ dysfunction or ...
In a study published in Nature Immunology on January 6, a research team led by Prof. Qian Youcun from the Shanghai Institute ...
New evidence shows that GLP-1 drugs might be more effective than aspirin at preventing colorectal cancer, while also ...
For millions suffering from chronic inflammatory diseases like inflammatory bowel disease (IBD), managing flare-ups often ...
Bowel cancer samples that have been stored for up to a century will be analysed to try to solve the mysterious rise of the ...
PALI-2108 is the first and only PDE4 inhibitor in development designed for targeted delivery to the terminal ileum and colon, addressing significant unmet needs in ulcerative colitis (UC) and fibroste ...
By Dennis Thompson HealthDay ReporterWEDNESDAY, Jan. 7, 2026 (HealthDay News) — Surgery should be a last resort for people ...
In UK, bowel cancer rates among under-24s have risen by 75% since early 1990s, while cases in people aged 25 to 49 have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback